The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125730591 12573059 1 I 2005 20160712 20160720 20160720 EXP US-ASTRAZENECA-2016SE75936 ASTRAZENECA 47.00 YR F Y 69.90000 KG 20160720 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125730591 12573059 1 SS LISINOPRIL. LISINOPRIL 1 Oral 0 5 MG TABLET QD
125730591 12573059 2 SS METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 Oral 50.0MG UNKNOWN 0 50 MG
125730591 12573059 3 PS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 21366 20 MG TABLET QD
125730591 12573059 4 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 21366 20 MG TABLET QD
125730591 12573059 5 SS CRESTOR ROSUVASTATIN CALCIUM 1 Oral 21366 20 MG TABLET QD
125730591 12573059 6 C ASPIRIN. ASPIRIN 1 Oral 0 81 MG QD
125730591 12573059 7 C GABAPENTIN. GABAPENTIN 1 Oral 100.0MG UNKNOWN 0 100 MG
125730591 12573059 8 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 0 25 MG QD
125730591 12573059 9 C ISOSORBIDE MONOHYDARTE 2 Oral 0 30 MG QD
125730591 12573059 10 C ISOSORBIDE MONOHYDARTE 2 Oral 0 30 MG QD
125730591 12573059 11 C FLUOXETINE FLUOXETINE HYDROCHLORIDE 1 Oral 0 60 MG QD
125730591 12573059 12 C TRAMADOL. TRAMADOL 1 Oral 50.0MG UNKNOWN 0 50 MG
125730591 12573059 13 C NITRO STAT 2 Sublingual 0.4MG UNKNOWN 0 .4 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125730591 12573059 1 Hypertension
125730591 12573059 2 Hypertension
125730591 12573059 3 Type IIa hyperlipidaemia
125730591 12573059 4 Chest pain
125730591 12573059 5 Arteriosclerosis
125730591 12573059 7 Neuropathy peripheral
125730591 12573059 8 Thyroid disorder
125730591 12573059 9 Chest pain
125730591 12573059 10 Prophylaxis
125730591 12573059 11 Depression
125730591 12573059 12 Pain
125730591 12573059 13 Chest pain

Outcome of event

Event ID CASEID OUTC COD
125730591 12573059 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125730591 12573059 Corrective lens user
125730591 12573059 Device occlusion
125730591 12573059 Intentional product misuse
125730591 12573059 Intervertebral disc degeneration
125730591 12573059 Myocardial infarction
125730591 12573059 Nausea
125730591 12573059 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125730591 12573059 1 201602 0
125730591 12573059 3 200410 0
125730591 12573059 4 200410 0
125730591 12573059 5 200410 0
125730591 12573059 6 2010 0
125730591 12573059 7 2010 0
125730591 12573059 8 2013 0
125730591 12573059 11 2005 0
125730591 12573059 12 2004 0
125730591 12573059 13 201602 0